Almac Creates Test to Predict Likelihood of Colon Cancer Recurring

A report outlining Almac Diagnostic’s new prognostic test to determine the risk of colon cancer recurrence was published in the online version of the Journal of Clinical Oncology.

Advertisement

The test included 73 patients with recurrent disease and 142 patients with no recurrence within 5 years of surgery. Researchers developed a gene signature, and in tests, the signature identified high-risk patients with a hazard ration of 2.62.

Related Articles on Colorectal Cancer:
Study: Poor Men More Likely to Die of Colorectal Cancer
Screening Baby Boomers for Hepatitis C During a Routine Colon Cancer Screening
Current, Former Smokers Face Elevated Colorectal Cancer Risk

Advertisement

Next Up in GI & Endoscopy

  • As colonoscopy demand rises, driven in part by more diagnostic referrals for patients under 55, GI leaders are also seeing…

  • Medical device company and surgical equipment manufacturer ConMed plans to exit its gastroenterology product lines.  ConMed’s gastroenterology segment is projected…

Advertisement

Comments are closed.